TickerFacts.

Biomerica Inc (BMRA): Operating Income

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2020-05-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$5.32M
Year ended 2026-05-31
$514.0K2011-05-31: -$132.3K2012-05-31: $505.0K2013-05-31: $514.0K2014-05-31: -$446.6K2015-05-31: -$670.6K2016-05-31: -$827.0K2017-05-31: -$954.6K2018-05-31: -$1.48M2019-05-31: -$2.41M2020-05-31: -$2.74M2021-05-31: -$7.50M2022-05-31: -$4.53M2023-05-31: -$7.22M2024-05-31: -$6.37M2025-05-31: -$5.14M2026-05-31: -$5.32M-$5.32M
2011-05-31 Operating Income (USD) 2026-05-31
Period endedOperating IncomeChange YoYSource filing
2026-05-31-$5.32Mn/m2026-08-31, From 2025-06-01
2025-05-31-$5.14Mn/m2026-08-31, From 2024-06-01
2024-05-31-$6.37Mn/m2025-08-29, From 2023-06-01
2023-05-31-$7.22Mn/m2024-08-28, From 2022-06-01
2022-05-31-$4.53Mn/m2023-08-25, From 2021-06-01
2021-05-31-$7.50Mn/m2022-08-29, From 2020-06-01
2020-05-31-$2.74Mn/c2021-10-14, From 2019-06-01
2019-05-31-$2.41Mn/m2020-08-31, From 2018-06-01
2018-05-31-$1.48Mn/m2019-08-29, From 2017-06-01
2017-05-31-$954.6Kn/m2018-08-29, From 2016-06-01
2016-05-31-$827.0Kn/m2017-08-29, From 2015-06-01
2015-05-31-$670.6Kn/m2016-08-29, From 2014-06-01
2014-05-31-$446.6Kn/m2015-08-31, From 2013-06-01
2013-05-31$514.0K+1.8%2014-08-29, From 2012-06-01
2012-05-31$505.0Kn/m2013-08-29, From 2011-06-01
2011-05-31-$132.3Kn/a2012-08-29, From 2010-06-01

Operating Income at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Biomerica Inc (BMRA)2026-05-31-$5.32Mn/m
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31-$51.12Mn/m
Anbio Biotechnology (NNNN)2025-12-31$5.77M+189.1%
Aspira Women's Health Inc. (AWHL)2025-12-31-$7.91Mn/m
Volitionrx Ltd (VNRX)2025-12-31-$21.74Mn/m
Celldex Therapeutics, Inc. (CLDX)2025-12-31-$287.37Mn/m
Immucell Corp (ICCC)2025-12-31$1.65Mn/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$16.98Mn/m
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$440.99Mn/m

Compare BMRA, IMDX, NNNN, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗